Immune escape and exploitation strategies of cytomegaloviruses: impact on and imitation of the major histocompatibility system
暂无分享,去创建一个
[1] U. Koszinowski,et al. Murine Cytomegalovirus Interference with Antigen Presentation Has Little Effect on the Size or the Effector Memory Phenotype of the CD8 T Cell Response1 , 2004, The Journal of Immunology.
[2] M. Groettrup,et al. A Cytomegalovirus Inhibitor of Gamma Interferon Signaling Controls Immunoproteasome Induction , 2004, Journal of Virology.
[3] B. Slobedman,et al. A Novel Viral Transcript with Homology to Human Interleukin-10 Is Expressed during Latent Human Cytomegalovirus Infection , 2004, Journal of Virology.
[4] V. Štolc,et al. Functional profiling of a human cytomegalovirus genome , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[5] S. Jonjić,et al. Pathogenesis of murine cytomegalovirus infection. , 2003, Microbes and infection.
[6] David C. Johnson,et al. Human Cytomegalovirus US2 Causes Similar Effects on Both Major Histocompatibility Complex Class I and II Proteins in Epithelial and Glial Cells , 2003, Journal of Virology.
[7] P. Bjorkman,et al. Crystal structure of HLA-A2 bound to LIR-1, a host and viral major histocompatibility complex receptor , 2003, Nature Immunology.
[8] Kouhei Tsumoto,et al. Human inhibitory receptors Ig-like transcript 2 (ILT2) and ILT4 compete with CD8 for MHC class I binding and bind preferentially to HLA-G , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[9] C. Sutherland,et al. Human Cytomegalovirus Glycoprotein UL16 Causes Intracellular Sequestration of NKG2D Ligands, Protecting Against Natural Killer Cell Cytotoxicity , 2003, The Journal of experimental medicine.
[10] L. Lanier,et al. NKG2D-mediated Natural Killer Cell Protection Against Cytomegalovirus Is Impaired by Viral gp40 Modulation of Retinoic Acid Early Inducible 1 Gene Molecules , 2003, The Journal of experimental medicine.
[11] D. Wolf,et al. For whom the bell tolls: protein quality control of the endoplasmic reticulum and the ubiquitin–proteasome connection , 2003, The EMBO journal.
[12] David C. Johnson,et al. Viral inhibition of MHC class II antigen presentation. , 2003, Trends in immunology.
[13] M. Menzies,et al. Ex Vivo Profiling of CD8+-T-Cell Responses to Human Cytomegalovirus Reveals Broad and Multispecific Reactivities in Healthy Virus Carriers , 2003, Journal of Virology.
[14] S. Riddell,et al. Intracellular Retention of the MHC Class I-Related Chain B Ligand of NKG2D by the Human Cytomegalovirus UL16 Glycoprotein1 , 2003, The Journal of Immunology.
[15] L. Brandén,et al. The Human Cytomegalovirus Protein UL16 Mediates Increased Resistance to Natural Killer Cell Cytotoxicity through Resistance to Cytolytic Proteins , 2003, Journal of Virology.
[16] J. Yewdell,et al. A single viral protein HCMV US2 affects antigen presentation and intracellular iron homeostasis by degradation of classical HLA class I and HFE molecules. , 2003, Blood.
[17] H. Reyburn,et al. Expression of the UL16 glycoprotein of Human Cytomegalovirus protects the virus-infected cell from attack by natural killer cells , 2003, BMC Immunology.
[18] A. Diefenbach,et al. Innate immune recognition by stimulatory immunoreceptors. , 2003, Current opinion in immunology.
[19] M. Smyth,et al. Functional interactions between dendritic cells and NK cells during viral infection , 2003, Nature Immunology.
[20] H. Rammensee,et al. Selective intracellular retention of virally induced NKG2D ligands by the human cytomegalovirus UL16 glycoprotein , 2003, European journal of immunology.
[21] U. Koszinowski,et al. Effective Inhibition of Kb- and Db-Restricted Antigen Presentation in Primary Macrophages by Murine Cytomegalovirus , 2003, Journal of Virology.
[22] J. Yewdell,et al. Viral interference with antigen presentation , 2002, Nature Immunology.
[23] P. Parham,et al. NK cell-mediated lysis of autologous HCMV-infected skin fibroblasts is highly variable among NK cell clones and polyclonal NK cell lines. , 2002, Clinical immunology.
[24] E. Mocarski,et al. Latent cytomegalovirus down-regulates major histocompatibility complex class II expression on myeloid progenitors. , 2002, Blood.
[25] Andrew J Davison,et al. Fundamental and accessory systems in herpesviruses. , 2002, Antiviral research.
[26] A. Scalzo. Successful control of viruses by NK cells--a balance of opposing forces? , 2002, Trends in microbiology.
[27] U. Koszinowski,et al. Major Histocompatibility Complex Class I Allele-specific Cooperative and Competitive Interactions between Immune Evasion Proteins of Cytomegalovirus , 2002, The Journal of experimental medicine.
[28] S. Riddell,et al. Association between immune recovery uveitis and a diverse intraocular cytomegalovirus-specific cytotoxic T cell response. , 2002, The Journal of infectious diseases.
[29] E. Mocarski. Immunomodulation by cytomegaloviruses: manipulative strategies beyond evasion. , 2002, Trends in microbiology.
[30] L. Picker,et al. Cytomegalovirus (CMV) phosphoprotein 65 makes a large contribution to shaping the T cell repertoire in CMV-exposed individuals. , 2002, The Journal of infectious diseases.
[31] D. Fremont,et al. Recognition of a virus-encoded ligand by a natural killer cell activation receptor , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[32] M. Huber,et al. Human Cytomegalovirus US7, US8, US9, and US10 Are Cytoplasmic Glycoproteins, Not Found at Cell Surfaces, and US9 Does Not Mediate Cell-to-Cell Spread , 2002, Journal of Virology.
[33] P. Tomasec,et al. UL40-mediated NK evasion during productive infection with human cytomegalovirus , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[34] D. Busch,et al. MCMV glycoprotein gp40 confers virus resistance to CD8+ T cells and NK cells in vivo , 2002, Nature Immunology.
[35] L. Lanier,et al. Direct Recognition of Cytomegalovirus by Activating and Inhibitory NK Cell Receptors , 2002, Science.
[36] T. Schall,et al. Potent Immunosuppressive Activities of Cytomegalovirus- Encoded Interleukin-10 , 2002, Journal of Virology.
[37] C. Sutherland,et al. UL16-Binding Proteins, Novel MHC Class I-Related Proteins, Bind to NKG2D and Activate Multiple Signaling Pathways in Primary NK Cells , 2002, The Journal of Immunology.
[38] U. Koszinowski,et al. The Multiple Immune-Evasion Genes of Murine Cytomegalovirus Are Not Redundant , 2001, The Journal of experimental medicine.
[39] U. Koszinowski,et al. The Murine Cytomegalovirus Immune Evasion Protein m4/gp34 Forms Biochemically Distinct Complexes with Class I MHC at the Cell Surface and in a Pre-Golgi Compartment1 , 2001, The Journal of Immunology.
[40] S. Riddell,et al. Costimulation of CD8αβ T cells by NKG2D via engagement by MIC induced on virus-infected cells , 2001, Nature Immunology.
[41] Daniel L. Popkin,et al. Novel Cell Type–Specific Antiviral Mechanism of Interferon γ Action in Macrophages , 2001, The Journal of experimental medicine.
[42] R. Armitage,et al. ULBPs, novel MHC class I-related molecules, bind to CMV glycoprotein UL16 and stimulate NK cytotoxicity through the NKG2D receptor. , 2001, Immunity.
[43] M. Blok,et al. The r144 Major Histocompatibility Complex Class I-Like Gene of Rat Cytomegalovirus Is Dispensable for both Acute and Long-Term Infection in the Immunocompromised Host , 2000, Journal of Virology.
[44] M. Smyth,et al. M144, a Murine Cytomegalovirus (Mcmv)-Encoded Major Histocompatibility Complex Class I Homologue, Confers Tumor Resistance to Natural Killer Cell–Mediated Rejection , 1999, The Journal of experimental medicine.
[45] P. Ghazal,et al. Murine cytomegalovirus infection down-regulates MHC class II expression on macrophages by induction of IL-10. , 1999, Journal of immunology.
[46] S. Jonjić,et al. Cytomegaloviral control of MHC class I function in the mouse , 1999, Immunological reviews.
[47] D. Cosman,et al. Human cytomegalovirus, MHC class I and inhibitory signalling receptors: more questions than answers , 1999, Immunological reviews.
[48] F. Takei,et al. Inhibition of NK cells by murine CMV-encoded class I MHC homologue m144. , 1998, Cellular immunology.
[49] P. Bjorkman,et al. Modulation of Natural Killer Cell Cytotoxicity in Human Cytomegalovirus Infection: The Role of Endogenous Class I Major Histocompatibility Complex and a Viral Class I Homolog , 1998, The Journal of experimental medicine.
[50] M. Heise,et al. Murine Cytomegalovirus Inhibits Interferon γ–induced Antigen Presentation to CD4 T Cells by Macrophages Via Regulation of Expression of Major Histocompatibility Complex Class II–associated Genes , 1998, The Journal of experimental medicine.
[51] H. Vally,et al. Inhibition of natural killer cells by a cytomegalovirus MHC class I homologue in vivo , 1997, Nature.
[52] O. Mandelboim,et al. The class I MHC homologue of human cytomegalovirus inhibits attack by natural killer cells , 1997, Nature.
[53] J. Xu,et al. Human cytomegalovirus latent gene expression in granulocyte-macrophage progenitors in culture and in seropositive individuals. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[54] William Arbuthnot Sir Lane,et al. The MHC class I homolog encoded by human cytomegalovirus binds endogenous peptides. , 1995, Immunity.
[55] L. Sun,et al. Multiple independent loci within the human cytomegalovirus unique short region down-regulate expression of major histocompatibility complex class I heavy chains , 1995, Journal of virology.
[56] H. Hengel,et al. MHC Class I–Subversive Gene Functions of Cytomegalovirus and their Regulation by Interferons–an Intricate Balance , 2004, Virus Genes.
[57] K. Früh,et al. Human cytomegalovirus inhibits tapasin-dependent peptide loading and optimization of the MHC class I peptide cargo for immune evasion. , 2004, Immunity.
[58] J. Bennink,et al. A survival game of hide and seek: cytomegaloviruses and MHC class I antigen presentation pathways. , 2003, Viral immunology.
[59] D. McGeoch,et al. The human cytomegalovirus genome revisited: comparison with the chimpanzee cytomegalovirus genome. , 2003, The Journal of general virology.
[60] David C. Johnson,et al. Human Cytomegalovirus US 2 Causes Similar Effects on Both Major Histocompatibility Complex Class I and II Proteins in Epithelial and Glial Cells , 2003 .
[61] U. Koszinowski,et al. Strategies for the identification and analysis of viral immune-evasive genes--cytomegalovirus as an example. , 2002, Current topics in microbiology and immunology.
[62] P. Tomasec,et al. Viral evasion of natural killer cells during human cytomegalovirus infection. , 2002, Current topics in microbiology and immunology.
[63] M. Kikkert,et al. The HCMV gene products US2 and US11 target MHC class I molecules for degradation in the cytosol. , 2002, Current topics in microbiology and immunology.
[64] F. Momburg,et al. Corking the bottleneck: the transporter associated with antigen processing as a target for immune subversion by viruses. , 2002, Current topics in microbiology and immunology.
[65] D. Sedmak,et al. Human cytomegalovirus inhibition of major histocompatibility complex transcription and interferon signal transduction. , 2002, Current topics in microbiology and immunology.
[66] M. Kretzler,et al. Interaction of DAP3 and FADD only after cellular disruption , 2002, Nature Immunology.
[67] Luiza Helena Falleiros-Carvalho. [Cytomegalovirus (CMV).]. , 1999, Jornal de pediatria.